EverspanThis Week in Longevity
15 interventions tracked across community trends, research velocity, grade changes, and active trials.
Trending in the Community
Top interventions by community discussion volume this week.
Synthetic peptide derived from gastric juice showing promise for tissue repair and wound healing in animal studies.
GLP-1 receptor agonist showing promising effects on metabolic health and potential longevity pathways through weight management and metabolic optimization.
An mTOR inhibitor showing lifespan extension in animal models, now under investigation for human aging.
NAD+ precursor supplement that research suggests may support cellular energy metabolism and healthy aging pathways.
Diabetes medication showing promise for aging and healthspan extension in research studies
Research Velocity Movers
Interventions with the fastest-growing publication counts.
47 publications in the last 12 months
12 publications in the last 12 months
3 publications in the last 12 months
18 publications in the last 12 months
12 publications in the last 12 months
Evidence Grade Changes
Interventions whose evidence grade changed this week.
No grade changes this week – all evidence grades are holding steady.
Clinical Trial Highlights
Active interventions with strong trial activity and research momentum.
500 human trials · 320 papers/year
200 human trials · 180 papers/year
500 human trials · 2800 papers/year
500 human trials · 450 papers/year
250 human trials · 420 papers/year
Get the weekly digest in your inbox
Stay informed with curated longevity research updates every Sunday.